Rare diseases
Investigational molecules
Locations
Back to Germany39 clinical trials in Blankenfelde-Mahlow, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)JNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
GermanyCorabotase for Moderate to Severe Glabellar Lines in Adults
GermanyStudy on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments
GermanyStudy on Guselkumab for Patients with Moderate-to-Severe Plaque Psoriasis
GermanyStudy of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy Comparing Risankizumab and Deucravacitinib for Adults with Moderate Plaque Psoriasis Eligible for Systemic Therapy
GermanyStudy on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Ruxolitinib Cream for Adults with Chronic Hand Eczema
GermanyStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
GermanyStudy on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
GermanyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating new therapeutic approaches for moderate to severe plaque psoriasis, including multiple clinical trials testing novel treatments and comparing their effectiveness to existing options.
Multiple promising compounds being investigated to expand treatment options for patients with persistent symptoms.
Innovative research focusing on moderate to severe atopic dermatitis, investigating both standalone treatments and combination therapies with topical corticosteroids.
Emphasis on developing solutions for patients who haven't responded well to conventional treatments.
Research encompassing various skin conditions including chronic hand eczema, vitiligo, and hidradenitis suppurativa.
Focus on developing effective treatments for conditions that significantly impact quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
